In rheumatoid arthritis (RA), miR-23a expression enhancement was shown to be associated with lower levels of inflammation, which can be explained by a downregulation of IL-17 expression and T cell differentiation to Th17 cells. The gene discussed is IL17A; the disease is rheumatoid arthritis.